1. Home
  2. ABOS vs BZUN Comparison

ABOS vs BZUN Comparison

Compare ABOS & BZUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABOS
  • BZUN
  • Stock Information
  • Founded
  • ABOS 1996
  • BZUN 2007
  • Country
  • ABOS United States
  • BZUN China
  • Employees
  • ABOS N/A
  • BZUN N/A
  • Industry
  • ABOS Biotechnology: Pharmaceutical Preparations
  • BZUN Catalog/Specialty Distribution
  • Sector
  • ABOS Health Care
  • BZUN Consumer Discretionary
  • Exchange
  • ABOS Nasdaq
  • BZUN Nasdaq
  • Market Cap
  • ABOS 84.2M
  • BZUN 275.9M
  • IPO Year
  • ABOS 2021
  • BZUN N/A
  • Fundamental
  • Price
  • ABOS $1.23
  • BZUN $4.50
  • Analyst Decision
  • ABOS Strong Buy
  • BZUN Strong Buy
  • Analyst Count
  • ABOS 3
  • BZUN 1
  • Target Price
  • ABOS $8.00
  • BZUN $4.20
  • AVG Volume (30 Days)
  • ABOS 182.5K
  • BZUN 703.4K
  • Earning Date
  • ABOS 11-11-2025
  • BZUN 08-28-2025
  • Dividend Yield
  • ABOS N/A
  • BZUN N/A
  • EPS Growth
  • ABOS N/A
  • BZUN N/A
  • EPS
  • ABOS N/A
  • BZUN N/A
  • Revenue
  • ABOS N/A
  • BZUN $1,349,630,922.00
  • Revenue This Year
  • ABOS N/A
  • BZUN $5.27
  • Revenue Next Year
  • ABOS N/A
  • BZUN $3.46
  • P/E Ratio
  • ABOS N/A
  • BZUN N/A
  • Revenue Growth
  • ABOS N/A
  • BZUN 7.73
  • 52 Week Low
  • ABOS $0.86
  • BZUN $2.12
  • 52 Week High
  • ABOS $3.36
  • BZUN $4.88
  • Technical
  • Relative Strength Index (RSI)
  • ABOS 39.55
  • BZUN 69.52
  • Support Level
  • ABOS $1.34
  • BZUN $3.74
  • Resistance Level
  • ABOS $1.47
  • BZUN $4.88
  • Average True Range (ATR)
  • ABOS 0.08
  • BZUN 0.35
  • MACD
  • ABOS -0.02
  • BZUN 0.11
  • Stochastic Oscillator
  • ABOS 7.69
  • BZUN 82.41

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including strategy and tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

Share on Social Networks: